Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: Current report 50 re insiders transactions (2013-04-22)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 50:Current report 50 re insiders transactions

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report 50 re insiders transactions.doc Current report 50 re insiders transactions

POLISH FINANCIAL SUPERVISION AUTHORITY









UNI - EN REPORT No 50 / 2013





Date of issue: 2013-04-22
Short name of the issuer
SOPHARMA AD
Subject
Current report 50 re insiders transactions
Official market - legal basis
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych
Unofficial market - legal basis
Contents of the report:
The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company ELPHARMA related to him, executed the following transactions related to shares in the Company:


Date and time of the settlement Operation Number of shares Unit price (BGN)
17.4.2013 Sale 4 000 2.5500
17.4.2013 Sale 730 2.5500
17.4.2013 Sale 5 000 2.5500
17.4.2013 Sale 56 2.5500
17.4.2013 Sale 5 000 2.5500
17.4.2013 Sale 10 000 2.5500
17.4.2013 Sale 10 000 2.5500
17.4.2013 Sale 10 000 2.5500
17.4.2013 Sale 5 000 2.5800
18.4.2013 Sale 2 000 2.5800
18.4.2013 Sale 6 000 2.5800
18.4.2013 Sale 3 000 2.5800
19.4.2013 Sale 3 000 2.5700
19.4.2013 Sale 5 000 2.5700
19.4.2013 Sale 5 000 2.5700
19.4.2013 Sale 2 000 2.5600
19.4.2013 Sale 10 000 2.5600
22.4.2013 Sale 5 000 2.5450
22.4.2013 Sale 1 500 2.5150
22.4.2013 Sale 1 000 2.5160
22.4.2013 Sale 2 000 2.5010
22.4.2013 Sale 1 000 2.5150
22.4.2013 Sale 10 000 2.5150
22.4.2013 Sale 5 000 2.5200
22.4.2013 Sale 1 000 2.5350
23.4.2013 Sale 3 000 2.5340
23.4.2013 Sale 10 000 2.5300
23.4.2013 Sale 10 000 2.5300
23.4.2013 Sale 10 000 2.5350
23.4.2013 Sale 3 000 2.5450


The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.
Annexes
File Description
Current report 50 re insiders transactions.doc
Current report 50 re insiders transactions.doc
Current report 50 re insiders transactions

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-04-22 Ognian Donev Executive Director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama